US 11,969,337 B2
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material
Robert D. Rehnke, St. Petersburg, FL (US)
Assigned to Bard Shannon Limited, Humacao, PR (US)
Filed by Bard Shannon Limited, Humacao, PR (US)
Filed on Apr. 21, 2021, as Appl. No. 17/236,163.
Application 17/236,163 is a continuation of application No. 16/827,030, filed on Mar. 23, 2020, granted, now 11,638,640.
Prior Publication US 2021/0290364 A1, Sep. 23, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 2/12 (2006.01); A61L 27/36 (2006.01); A61F 2/00 (2006.01)
CPC A61F 2/12 (2013.01) [A61L 27/3604 (2013.01); A61F 2002/0081 (2013.01); A61F 2210/0004 (2013.01); A61F 2230/0069 (2013.01); A61F 2230/0071 (2013.01); A61F 2240/002 (2013.01); A61F 2250/0023 (2013.01)] 25 Claims
OG exemplary drawing
 
1. An implantable prosthesis comprising:
a three-dimensional, tissue infiltratable body of biocompatible material including a proximal end, a distal end spaced from the proximal end, a core extending along a core axis from the proximal end to the distal end, and a plurality of chambers arranged around the core axis and extending in an outward radial direction away from the core axis, wherein each of the plurality of chambers extends along a corresponding chamber axis which is transverse to the longitudinal axis; and
a plurality of supports arranged on the body around the core axis, the plurality of supports configured to stabilize the body, each of the plurality of supports extending in an outward radial direction away from the core axis.